Cabometyx 40 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FMDZ8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,467
Award facts
- Contract value 100% obligated
- $50,466.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $50,466.54 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, with an ultimate completion date of December 8, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support Department of Defense pharmaceutical supply needs globally.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal military medical system, with its parent IDC—contract SPE2DR—authorized through December 31, 2036, featuring a $499.999 billion ceiling value. The company's extensive product portfolio encompasses oncology treatments, immunosuppressants, biologics, vaccines, and specialty pharmaceuticals, positioning it to fulfill the diverse medical requirements of military healthcare facilities worldwide. As a registered Small Business Administration-certified woman-owned small business since 2001, DMS Pharmaceutical Group leverages its small business status to compete effectively while maintaining consistent contract performance across multiple therapeutic categories and delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division.
Quick answers
Who was awarded contract SPE2DR26FMDZ8?
SPE2DR26FMDZ8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FMDZ8 worth?
The government has obligated $50,467 on SPE2DR26FMDZ8.
Is contract SPE2DR26FMDZ8 an order under another contract?
Yes. SPE2DR26FMDZ8 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMDZ8 competed?
The extent of competition for SPE2DR26FMDZ8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award